Provectus Biopharmaceuticals, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Knoxville TN United States (2002)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2005
NCT00219843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Provectus Biopharmaceuticals Australia Pty Ltd | Provectus Pharmaceuticals | Provectus Pharmaceuticals, Inc.